Johnson and Johnson

The Society for Maternal-Fetal Medicine issued new guidance affirming acetaminophen (Tylenol) as the first-line treatment for pain and fever during pregnancy, contradicting prior warnings from the Trump administration. Health and Human Services Secretary Robert F. Kennedy Jr. directed the FDA to shift autism research toward environmental causes, while the FDA had previously proposed label changes for acetaminophen despite no proven link to autism.

The Society for Maternal-Fetal Medicine issued new clinical guidance affirming acetaminophen (Tylenol) as the first-line treatment for pain and fever during pregnancy, contradicting the Trump administration's earlier caution about its potential link to autism. The guidance notes that while some studies associate maternal acetaminophen use with neurodevelopmental risks, causality remains unproven. Health and Human Services Secretary Robert F. Kennedy Jr. has directed the FDA to shift autism research toward environmental causes.

The Society for Maternal-Fetal Medicine published new clinical guidance affirming acetaminophen (Tylenol) as the first-line treatment for pain and fever during pregnancy, contradicting prior Trump administration warnings about its potential link to autism. Health and Human Services Secretary Robert F. Kennedy Jr. directed the FDA to shift autism research toward environmental causes, while Texas' Attorney General Ken Paxton sued Johnson and Johnson over alleged risks of acetaminophen use during pregnancy.

The Society for Maternal-Fetal Medicine reaffirmed acetaminophen (Tylenol) as the first-line treatment for pain and fever during pregnancy, countering the Trump administration's previous warnings about its potential link to autism. Health and Human Services Secretary Robert F. Kennedy Jr. directed the FDA to focus autism research on environmental causes, while Texas Attorney General Ken Paxton sued Johnson and Johnson over alleged misleading claims about Tylenol's safety during pregnancy.

The Society for Maternal-Fetal Medicine published new clinical guidance affirming acetaminophen (Tylenol) as the first-line treatment for pain and fever during pregnancy, contradicting prior Trump administration warnings about potential autism risks. Health and Human Services Secretary Robert F. Kennedy Jr. directed the FDA to shift autism research toward environmental causes, while the organization emphasized methodological limitations in studies linking acetaminophen to neurodevelopmental outcomes.

The Society for Maternal-Fetal Medicine updated its guidance to recommend acetaminophen (Tylenol) as the first-line treatment for pain and fever during pregnancy, contradicting previous Trump administration warnings about a potential link to autism. The guidance highlights methodological issues in studies suggesting such a link, while the FDA has not yet changed Tylenol's label despite initial plans to do so following Trump's claims.

The Society for Maternal-Fetal Medicine updated its guidance to recommend acetaminophen (Tylenol) as the first-line treatment for pain and fever during pregnancy, countering previous claims by the Trump administration about its link to autism. The FDA is considering label changes, and a lawsuit against Johnson and Johnson was filed by Texas' Republican Attorney General Ken Paxton.

The Society for Maternal-Fetal Medicine reaffirmed acetaminophen (Tylenol) as the first-line treatment for pain and fever during pregnancy, contradicting the Trump administration's earlier caution about potential autism risks. Health and Human Services Secretary Robert F. Kennedy Jr. directed the FDA to shift autism research toward environmental causes, while the FDA had proposed label changes for acetaminophen products based on unproven autism links.